BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20166216)

  • 1. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
    Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
    Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory.
    Gning I; Trask PC; Mendoza TR; Harle MT; Gutierrez KA; Kitaka SA; Sherman SI; Cleeland CS
    Oncology; 2009; 76(1):59-68. PubMed ID: 19052478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.
    Nejmi M; Wang XS; Mendoza TR; Gning I; Cleeland CS
    J Pain Symptom Manage; 2010 Jul; 40(1):75-86. PubMed ID: 20619213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
    Rosenthal DI; Mendoza TR; Chambers MS; Asper JA; Gning I; Kies MS; Weber RS; Lewin JS; Garden AS; Ang KK; S Wang X; Cleeland CS
    Head Neck; 2007 Oct; 29(10):923-31. PubMed ID: 17358040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients.
    Wang XS; Wang Y; Guo H; Mendoza TR; Hao XS; Cleeland CS
    Cancer; 2004 Oct; 101(8):1890-901. PubMed ID: 15386315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
    Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
    J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
    Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patients.
    Wang XS; Laudico AV; Guo H; Mendoza TR; Matsuda ML; Yosuico VD; Fragante EP; Cleeland CS
    J Pain Symptom Manage; 2006 Jun; 31(6):542-52. PubMed ID: 16793494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients.
    Lin CC; Chang AP; Cleeland CS; Mendoza TR; Wang XS
    J Pain Symptom Manage; 2007 Feb; 33(2):180-8. PubMed ID: 17280923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
    Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom Inventory.
    Ivanova MO; Ionova TI; Kalyadina SA; Uspenskaya OS; Kishtovich AV; Guo H; Mendoza TR; Novik A; Cleeland CS; Wang XS
    J Pain Symptom Manage; 2005 Nov; 30(5):443-53. PubMed ID: 16310618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of the Korean version of the M. D. Anderson Symptom Inventory.
    Yun YH; Mendoza TR; Kang IO; You CH; Roh JW; Lee CG; Lee WS; Lee KS; Bang SM; Park SM; Cleeland CS; Wang XS
    J Pain Symptom Manage; 2006 Apr; 31(4):345-52. PubMed ID: 16632082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical utility of the MDASI-BT in patients with brain metastases.
    Armstrong TS; Gning I; Mendoza TR; Weinberg JS; Gilbert MR; Tortorice ML; Cleeland CS
    J Pain Symptom Manage; 2009 Mar; 37(3):331-40. PubMed ID: 18676120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure.
    Fadol A; Mendoza T; Gning I; Kernicki J; Symes L; Cleeland CS; Lenihan D
    J Card Fail; 2008 Aug; 14(6):497-507. PubMed ID: 18672198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation and Application of the Chinese Version of the M. D. Anderson Symptom Inventory Gastrointestinal Cancer Module (MDASI-GI-C).
    Chen RW; Yang SL; Xu ZY; Peng M; Chen MN; Wang QS; Chang J; Hu JL
    J Pain Symptom Manage; 2019 Apr; 57(4):820-827. PubMed ID: 30684634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
    Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
    J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory.
    Tseng TH; Cleeland CS; Wang XS; Lin CC
    Cancer Nurs; 2008; 31(3):E9-16. PubMed ID: 18453871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
    Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
    Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greek M.D. Anderson Symptom Inventory: validation and utility in cancer patients.
    Mystakidou K; Cleeland C; Tsilika E; Katsouda E; Primikiri A; Parpa E; Vlahos L; Mendoza T
    Oncology; 2004; 67(3-4):203-10. PubMed ID: 15557779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
    Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
    Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.